H. El Housni

发表

Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn’s disease and ulcerative colitis

K. Van Steen, P. Rutgeerts, D. Franchimont, 2004, Gut.

Global histone deacetylase enzymatic activity is an independent prognostic marker associated with a shorter overall survival in chronic lymphocytic leukemia patients

H. El Housni, L. Lagneaux, D. Bron, 2014, Epigenetics.

Chromosomal translocations as a mechanism of BRAF activation in two cases of large congenital melanocytic nevi.

G. Ghanem, G. Vassart, H. El Housni, 2007, The Journal of investigative dermatology.

A real-time polymerase chain reaction assay for rapid, sensitive, and specific quantification of the JAK2V617F mutation using a locked nucleic acid-modified oligonucleotide.

J. Philippé, B. Verhasselt, H. El Housni, 2010, The Journal of molecular diagnostics : JMD.

Illustrative cases for monitoring by quantitative analysis of BRAF/NRAS ctDNA mutations in liquid biopsies of metastatic melanoma patients who gained clinical benefits from anti-PD1 antibody therapy

B. Neyns, V. del Marmol, H. El Housni, 2018, Melanoma research.

Genotypic and gene expression studies in congenital melanocytic nevi: insight into initial steps of melanotumorigenesis.

G. Ghanem, G. Vassart, H. El Housni, 2009, The Journal of investigative dermatology.

One-Step duplex droplet digital PCR for WT1 overexpression.

H. El Housni, P. Heimann, P. Cochaux, 2020, The Journal of molecular diagnostics : JMD.

Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale

D. Colomer, R. Zadro, N. Cross, 2016, Leukemia.

Identification of chronic myeloid leukemia patients treated with imatinib who are potentially eligible for treatment discontinuation by assessing real-life molecular responses on the international scale in a EUTOS-certified lab.

W. Pluymers, H. El Housni, P. Heimann, 2018, Leukemia research.

Single-nucleotide polymorphism genotyping by melting analysis of dual-labeled probes: examples using factor V Leiden and prothrombin 20210A mutations.

J. Parma, G. Vassart, H. El Housni, 2003, Clinical chemistry.

Cloning and sequence analysis of human calcyphosine complementary DNA.

J. Dumont, D. Christophe, H. El Housni, 1997, Biochimica et biophysica acta.

Thrombophilic Factors Do Not Predict Outcomes in Renal Transplant Recipients Under Prophylactic Acetylsalicylic Acid

P. Vereerstraeten, D. Abramowicz, M. Abramowicz, 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Limitations and practical procedure in BclII-Ig heavy chain gene rearrangement real-time quantitative polymerase chain reaction.

S. Swillens, H. El Housni, P. Heimann, 2006, The Journal of molecular diagnostics : JMD.

Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA.

Paul Metcalfe, Helen E White, Susan Branford, 2010, Blood.

Gene Expression Profiling Defines ATP as a Key Regulator of Human Dendritic Cell Functions1

J. Boeynaems, H. El Housni, F. Libert, 2007, The Journal of Immunology.

REFLECTIONS AND PROPOSALS TO ASSURE QUALITY IN MOLECULAR DIAGNOSTICS

H. El Housni, M. Raymaekers, O. Soetens, 2011, Acta clinica Belgica.

Fusion of a novel gene, RCC17, to the TFE3 gene in t(X;17)(p11.2;q25.3)-bearing papillary renal cell carcinomas.

E. Petty, G. Vassart, H. El Housni, 2001, Cancer research.

A rare case of false positive in a yeast two-hybrid screening: the selection of rearranged bait constructs that produce a functional gal4 activity.

I. Pirson, D. Christophe, H. El Housni, 1998, Analytical biochemistry.

Circulating tumor DNA in early response assessment and monitoring of advanced colorectal cancer treated with a multi-kinase inhibitor

C. Sotiriou, C. Desmedt, P. Flamen, 2018, Oncotarget.

Clinical Validation of Targeted Next Generation Sequencing for Colon and Lung Cancers

Sabine Tejpar, Isabelle Salmon, I. Salmon, 2015, PloS one.

GUIDELINES FOR AN INTEGRATED DIAGNOSTIC APPROACH OF CHRONIC LYMPHOPROLIFERATIVE DISORDERS IN THE ROUTINE LABORATORY OF HAEMATOLOGY IN BELGIUM

P. Saussoy, P. Vannuffel, H. El Housni, 2009, Acta clinica Belgica.

A novel approach for BCR‐ABL1 standardization to improve International Scale estimation

P. Saussoy, P. Vannuffel, B. Cauwelier, 2016, International journal of laboratory hematology.

A certified plasmid reference material for the standardisation of BCR–ABL1 mRNA quantification by real-time quantitative PCR

H Emons, V Kairisto, S Trapmann, 2014, Leukemia.

TCF7L2 polymorphism associates with new-onset diabetes after transplantation.

D. Abramowicz, M. Abramowicz, K. Wissing, 2009, Journal of the American Society of Nephrology : JASN.

Combined locked nucleic acid and molecular beacon technologies for sensitive detection of the JAK2V617F somatic single-base sequence variant.

H. El Housni, P. Heimann, F. Lambert, 2006, Clinical chemistry.

Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy

B. Neyns, V. del Marmol, M. Keyaerts, 2019, Journal of Translational Medicine.

Instant evaluation of the absolute initial number of cDNA copies from a single real-time PCR curve.

Stéphane Swillens, S. Swillens, H. El Housni, 2004, Nucleic acids research.

[Medical genetics service].

J. Parma, M. Abramowicz, G. Vassart, 2002, Revue medicale de Bruxelles.

Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy

B. Neyns, V. del Marmol, M. Keyaerts, 2019, Journal of Translational Medicine.